Works matching IS 13518216 AND DT 2014 AND VI 20 AND IP 5


Results: 24
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Efficacy and safety of a recombinant factor IX (Bax326)<sup>a</sup> in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.

    Published in:
    Haemophilia, 2014, v. 20, n. 5, p. 651, doi. 10.1111/hae.12419
    By:
    • WINDYGA, J.;
    • LISSITCHKOV, T.;
    • STASYSHYN, O.;
    • MAMONOV, V.;
    • GHANDEHARI, H.;
    • CHAPMAN, M.;
    • FRITSCH, S.;
    • WONG, W.-Y.;
    • PAVLOVA, B. G.;
    • ABBUEHL, B. E.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24